Miragen Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $510k | 22k | 22.75 |
| 2024-06-30 | $149k | 11k | 13.01 |
| 2024-03-31 | $202k | 12k | 17.51 |
| 2023-12-31 | $223k | 10k | 21.78 |
| 2023-09-30 | $233k | 15k | 15.34 |
| 2023-06-30 | $211k | 8.9k | 23.79 |
| 2023-03-31 | $233k | 9.1k | 25.44 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates